# Virtual Reality in Chronic Conditions: An Umbrella Review

**Authors:** Ilaria Marcomini, Giulia Villa, Laura Ingrande, Gaia Latini, Andrea Poliani, Duilio Fiorenzo Manara, Debora Rosa

PMC · DOI: 10.3390/nursrep16020057 · 2026-02-10

## TL;DR

This review summarizes evidence that virtual reality can help manage chronic conditions by improving physical, respiratory, and psychological outcomes.

## Contribution

The study provides a comprehensive synthesis of existing systematic reviews and meta-analyses on VR for chronic conditions.

## Key findings

- VR showed significant improvements in respiratory outcomes, functional mobility, and psychological symptoms.
- Adverse events like cybersickness were mild but reported.
- Cognitive effects of VR were mixed across studies.

## Abstract

Background. Virtual reality (VR) is emerging as a non-pharmacological tool to support rehabilitation and self-management. Evidence of its effectiveness, however, remains fragmented. This umbrella review synthesized systematic reviews and meta-analyses on VR interventions in chronic conditions. Methods. Following the Joanna Briggs Institute Manual for Evidence Synthesis, comprehensive searches were conducted in MEDLINE, CINAHL, Cochrane Database, Web of Science, and Scopus. Eligible studies were systematic reviews and meta-analyses assessing VR interventions. Two reviewers independently performed screening, quality appraisal, and data extraction. Results. Seventeen reviews, including 229 primary studies, were analyzed. Stroke and chronic obstructive pulmonary disease were most frequently investigated. VR tools ranged from web- and smartphone-based systems to wearable devices and interactive games. Significant improvements were reported in respiratory outcomes, functional mobility, balance, and psychological symptoms. Cognitive effects were mixed. Reported adverse events, mainly cybersickness and dizziness, were mild. Conclusions. VR may improve physical, respiratory, psychological, and selected cognitive outcomes in chronic conditions. Despite study heterogeneity, evidence supports its integration into chronic care. Future work should standardize protocols, assess long-term effects, broaden target populations, and address equity and ethical issues to fully realize VR’s potential as a person-centered tool.

## Linked entities

- **Diseases:** chronic obstructive pulmonary disease (MONDO:0005002), stroke (MONDO:0005098)

## Full-text entities

- **Genes:** REV3L (REV3 like, DNA directed polymerase zeta catalytic subunit) [NCBI Gene 5980] {aka POLZ, REV3}, REV1 (REV1 DNA directed polymerase) [NCBI Gene 51455] {aka AIBP80, REV1L}
- **Diseases:** chronic musculoskeletal disorders (MESH:D009140), Depression (MESH:D003866), cognitive impairment (MESH:D003072), chronic diseases (MESH:D002908), multiple sclerosis (MESH:D009103), dizziness (MESH:D004244), COPD (MESH:D029424), Fatigue (MESH:D005221), functional (MESH:D003291), Stroke (MESH:D020521), eye strain (MESH:D013180), respiratory impairments (MESH:D012131), fall injuries (MESH:C537863), Pain (MESH:D010146), CCA (MESH:D000080041), injury to (MESH:D014947), Conditions (MESH:D020763), Anxiety (MESH:D001007), Dyspnea (MESH:D004417), cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943612/full.md

---
Source: https://tomesphere.com/paper/PMC12943612